New developments in biomarkers for lysosomal storage disorders

Johannes M. Aerts

doi:10.1016/S0149-2918(08)80075-6

Research Article| Volume 30, SUPPLEMENT 3, S92-S93, 2008

New developments in biomarkers for lysosomal storage disorders

Johannes M. Aerts, PhD
Johannes M. Aerts
Correspondence
Address correspondence to: Johannes M. Aerts, PhD, Department of Medical Biochemistry, Academic Medical Center, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands.
Contact
Affiliations
Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Search for articles by this author

DOI:https://doi.org/10.1016/S0149-2918(08)80075-6

This paper is only available as a PDF. To read, Please Download here.

To read this article in full you will need to make a payment

Purchase one-time access:

One-time access price info

For academic or personal research use, select 'Academic and Personal'
For corporate R&D use, select 'Corporate R&D Professionals'

Subscribe:

Already a print subscriber? Claim online access

Already an online subscriber? Sign in

Register: Create an account

Institutional Access: Sign in to ScienceDirect

References

- Aerts JM
- Hollak CE
Plasma and metabolic abnormalities in Gaucher's disease.
Baillieres Clin Haematol. 1997; 10: 691-709
- Hollak CE
- Evers L
- Aerts JM
- van Oers MH
Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease.
Blood Cells Mol Dis. 1997; 23: 201-212
- Michelakakis H
- Spanou C
- Kondyli A
- et al.
Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease.
Biochim Biophys Acta. 1996; 1317: 219-222
- Hollak CE
- van Weely S
- van Oers MH
- Aerts JM
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
J Clin Invest. 1994; 93: 1288-1292
- Schoonhoven A
- Rudensky B
- Elstein D
- et al.
Monitoring of Gaucher patients with a novel chitotriosidase assay.
Clin Chim Acta. 2007; 381: 136-139
- Boot RG
- Renkema GH
- Verhoek M
- et al.
The human chitotriosidase gene. Nature of inherited enzyme deficiency.
J Biol Chem. 1998; 273: 25680-25685
- Boot RG
- Verhoek M
- de Fost M
- et al.
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: A novel surrogate marker for assessing therapeutic intervention.
Blood. 2004; 103: 33-39
- Deegan PB
- Moran MT
- McFarlane I
- et al.
Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease.
Blood Cells Mol Dis. 2005; 35: 259-267
- van Breemen MJ
- de Fost M
- Voerman JS
- et al.
Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP- 1beta levels in type 1 Gaucher disease.
Biochim Biophys Acta. 2007; 1772: 788-796
- Vissers JP
- Langridge JI
- Aerts JM
Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease.
Mol Cell Proteomics. 2007; 6: 755-766
- Groener JE
- Poorthuis BJ
- Kuiper S
- et al.
HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma.
Clin Chem. 2007; 53: 742-747
- Ghauharali-van der Vlugt K
- Langeveld M
- Poppema A
- et al.
Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease.
Clin Chim Acta. 2008; 389: 109-113
- Aerts JM
- Groener JE
- Kuiper S
- et al.
Elevated globotriaosylsphingosine is a hallmark of Fabry disease.
Proc Natl Acad Sci U S A. 2008; 105: 2812-2817

Article info

Identification

DOI: https://doi.org/10.1016/S0149-2918(08)80075-6

Copyright

ScienceDirect

Access this article on ScienceDirect

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

New developments in biomarkers for lysosomal storage disorders

Purchase one-time access:

Subscribe:

References

Article info

Identification

Copyright

ScienceDirect

Related Articles